Numeral Ltd JSE:XII:
JSE: XII - UPDATE ON HEALTHCARE AND BIOTECH STRATEGY, INVESTMENTS AND THE FINALISATION OF AUDITED RESULTS
NUMERAL - TO EXIT INVESTMENTS IN LONGEVITY AND ISOPHARM
NUMERAL - INCREASES SHAREHOLDING IN CRYO-SAVE TO 51% FOR YEAR ENDED FEB 2026
NUMERAL - MAKES FIRST STRATEGIC INVESTMENT IN WESTMED HEALTHCARE PLATFORM
NUMERAL - LAUNCHES BOOST & RECOVERY PREMIUM WELLNESS AND RECOVERY CONCEPT